Sonoma Pharmaceuticals (SNOA) Non-cash Items (2013 - 2025)

Sonoma Pharmaceuticals' Non-cash Items history runs 13 years deep, the most recent figure standing at $39080.0 for Q4 2025.

• In Q4 2025, Non-cash Items rose 24.93% year-over-year to $39080.0; the TTM figure through Dec 2025 stood at $39080.0 (up 24.93% YoY), while the FY2025 annual figure was $39751.0, down 94.31% from the prior year.
• Non-cash Items was $39080.0 for Q4 2025 at Sonoma Pharmaceuticals, up from $35353.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $698454.0 in Q1 2024 to a low of $28335.0 in Q3 2024.
• Historically, Non-cash Items has averaged $247511.2 across 5 years, with a median of $156323.5 in 2022.
• The sharpest annual moves came in 2021 and 2024: Non-cash Items soared 955.34% in 2021, then sank 94.83% in 2024.
• A 5-year view of Non-cash Items shows it stood at $86200.0 in 2021, then surged by 148.99% to $214626.0 in 2022, then surged by 181.89% to $605000.0 in 2023, then tumbled by 94.83% to $31282.0 in 2024, then climbed by 24.93% to $39080.0 in 2025.
• The last three Non-cash Items figures came in at $39080.0 (Q4 2025), $35353.0 (Q3 2025), and $39177.0 (Q2 2025), per Business Quant data.